Page last updated: 2024-08-25

artemether and cgp-56697

artemether has been researched along with cgp-56697 in 142 studies

Research

Studies (142)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	4 (2.82)	18.2507
2000's	4 (2.82)	29.6817
2010's	13 (9.15)	24.3611
2020's	121 (85.21)	2.80

Authors

Authors	Studies
Bojang, K; Doherty, T; Gathmann, I; Gemperli, B; Greenwood, B; Haywood, M; Jaffar, S; Jones, P; McAdam, K; Obaro, S; Pinder, M; Royce, C; Snounou, G; von Seidlein, L	1
Abdulla, S; Beck, HP; Gathmann, I; Hatz, C; Kibatala, P; Mull, R; Royce, C; Schellenberg, D; Tanner, M	1
Ezzet, F; Karbwang, J; Mull, R	1
Farkad, E; Karbwang, J; Mull, R; Na-Bangchang, K; Tasanor, U; Thanavibul, A	1
Bindschedler, M; Ezzet, F; Lefèvre, G; Meyer, I; Schaeffer, N; Thomsen, MS	1
Adaramoye, OA; Ademowo, OG; Akinsanya, AM; Fafunso, MA; Nneji, CM; Osaimoje, DO	1
Kuhn, T; Wang, Y	1
Arinaitwe, E; Bigira, V; Dorsey, G; Gasasira, A; Homsy, J; Kakuru, A; Kamya, MR; Katrak, S; Sandison, TG; Tappero, JW; Wanzira, H	1
Oguonu, T; Okafor, HU; Shu, EN	1
Ali, S; Lindegardh, N; Najmi, MH; Tarning, J	1
Bashraheil, M; Bassat, Q; González, R; Kipkeu, C; Lefèvre, G; Lyimo, J; Machevo, S; Maiga, H; Mårtensson, A; Menéndez, C; Nahum, A; Nwaiwu, O; Ogutu, B; Ouma, P; Ubben, D; Walter, V	1
Abiodun, OO; Akinbo, J; Ojurongbe, O	1
Azandossessi, C; Damien, G; de Tove, YS; Kinde Gazard, D; Lawani, S; Ogouyèmi-Hounto, A; Remoue, F	1
Cohen, J; Kasozi, H; Saran, I; Yavuz, E	1
Álvarez-Larrotta, C; Aponte, S; Bernal, SD; González, C; Guerra, ÁP; Knudson-Ospina, A; Restrepo, C; Yasnot, MF	1
Beavogui, AH; Borghini-Fuhrer, I; Djimdé, AA; Duparc, S; Felices, M; Funck-Brentano, C; Khan, Y; Ouedraogo, JB; Ouologuem, N; Sagara, I; Sirima, SB; Soulama, I; Voiriot, P	1
Banda, CG; Barnes, KI; Maartens, G	1
Amara, A; Khoo, S; Lamorde, M; Waitt, C; Walimbwa, S	1
Bierhoff, M; Grobusch, MP; van Gool, T; van Hattem, JM; van Vugt, M; Visser, BJ	1
Obiebi, IP	1
Fungula, B; Inocencio da Luz, R; Kalabuanga, M; Lula Ntamba, Y; Lutumba, P; Muhindo Mavoko, H; Ntamabyaliro Nsengi, PM; Tona Lutete, G; Van Geertruyden, JP	1
Badjanga, BB; Day, NPJ; Fanello, C; Hoglund, RM; Jackson, NV; Kabedi, C; Kayembe, D; Lee, SJ; McGready, R; Nosten, F; Onyamboko, MA; Tarning, J; Turner, GDH; White, NJ	1
Abdullahi, ST; Bakare-Odunola, MT; Bolarinwa, RA; Khoo, S; Olagunju, A; Olarewaju, OJ; Owen, A; Soyinka, JO; Tarning, J; Winterberg, M	1
Aweeka, F; Huang, L; Hughes, E; Kajubi, R; Mwebaza, N; Mwima, MW; Nguyen, V; Nyunt, MM; Orukan, F; Parikh, S	1
Beshir, KB; Lubis, CP; Lubis, IND; Lubis, M; Sutherland, CJ; Wijaya, H	1
Amir, A; De Silva, JR; Ghozali, AH; Lai, MY; Lau, YL; Liew, JWK; Mat Salleh, NH; Ng, DC; Rahman, MFA; Samsusah, S; Tan, JH	1
Arroyo-Arroyo, MI; Barnes, KI; Bastiaens, GJH; Bjorkman, A; Bousema, T; Brown, JM; Chen, I; Craig, E; D'Alessandro, U; Dicko, A; Drakeley, CJ; El-Sayed, BB; Elzaki, SG; Eziefula, AC; Gonçalves, BP; Gosling, R; Guerin, PJ; Humphreys, GS; Kariuki, S; Kwambai, TK; Maestre, AE; Martensson, A; Mosha, D; Mwaiswelo, RO; Ngasala, BE; Okebe, J; Price, RN; Raman, J; Roh, ME; Samuels, AM; Sawa, P; Smit, MR; Stepniewska, K; Stone, WJR; Tiono, AB	1
Clark, RL	1
Iribhogbe, OI; Odoya, EM	1
Al Khaja, KAJ; Sequeira, RP	1
Cargill, Z; Chu, C; Gilder, ME; McGready, R; Min, AM; Nosten, F; Phyo, AP; Poe, H; Saito, M; San, TD; White, NJ; Yotyingaphiram, W	1
Denti, P; Kawuma, AN; Khoo, S; Lamorde, M; Pillai, GC; Walimbwa, SI; Wasmann, RE	1
Baguiya, A; Barry, N; Dianda, F; Héma, A; Hien, D; Kaboré, JMT; Kiba Koumaré, A; Kouanda, S; Nombré, Y; Savadogo, Y; Siribie, M; Sirima, SB; Soulama, I; Tchouatieu, AM; Tiono, AB	1
Deng, C; Liang, Y; Lu, C; Song, J; Tan, B; Wang, Q; Wu, W; Xu, Q; Zhang, H; Zhou, C	1
André, K; Bondo, BJ; Cândido, ALM; Caquece, F; Dimbu, PR; Ferreira, CM; Fortes, F; Garcia, LEA; Horth, R; Jandondo, D; Kelley, J; Labuda, S; Lucchi, N; Martins, JF; Morais, JFM; Nieto Andrade, B; Patel, D; Pembele, G; Pluciński, MM; Ponce de León, G; Svigel, SS; Talundzic, E	1
Rasmussen, C; Ringwald, P	1
Abba, T; Angora, EK; Assi, SB; Bedia, VA; Daho, AK; Emmanuel, B; Kiki-Barro, PMC; Konate, AA; Menan, H; Tiacoh, LN; Toure, OA; Yavo, W	1
Beshir, KB; Chijioke-Nwauche, I; Nwauche, CA; Oguike, MC; Sutherland, CJ	1
Bamadio, A; Barry, N; Beshir, KB; Compaore, YD; Coulibaly, M; Coulibaly, SA; Dama, S; Dao, F; Dara, N; Diallo, N; Diarra, A; Djimde, A; Fofana, B; Kaboré, JM; Kabore, NT; Kodio, A; Maurice, OS; Nikiema, F; Ouédraogo, JB; Sagara, I; Sirima, SB; Sombie, S; Somé, FA; Soulama, I; Sutherland, CJ; Togo, AH; Traore, A; Traore, OB; Zongo, I	1
Ali, R; Attah, S; Ekoh, OC; Okafor, S; Okoro, U; Ugwu, D; Ugwuja, D	1
Bancone, G; Carrara, VI; Chu, C; Duanguppama, J; Gilder, ME; Haohankhunnatham, W; Imwong, M; Konghahong, K; Lee, SJ; McGready, R; Min, AM; Nosten, F; Paw, MK; Phyo, AP; Pimanpanarak, M; Proux, S; Saito, M; Singhasivanon, P; Tun, NW; Turner, C; Viladpai-Nguen, J; White, NJ	1
Baltzell, K; Benjamin-Chung, J; Bhangu, K; Dlamini, B; Dlamini, N; Dufour, MK; Gosling, R; Greenhouse, B; Helb, D; Hsiang, MS; Kalungero, M; Kunene, S; Malambe, C; Maphalala, G; Mngadi, N; Nhlabathi, N; Ntshalintshali, N; Pindolia, D; Prach, LM; Tesfa, G; Vilakati, S; Whittemore, B	1
Gandhi, P; Renner, KC; Schmitt, EK; Straimer, J	1
Callery, JJ; Ean, M; Imwong, M; Maude, RJ; Mukaka, M; Peto, TJ; Sokha, M; Sovannaroth, S; Soviet, O; Tarning, J; Tripura, R; von Seidlein, L; Vongpromek, R; Waithira, N	1
Baptista-Fernandes, T; Benavente, ED; Caldas, JP; Campino, S; Cardoso, M; Clark, TG; Conceição, C; Domingos, J; Mansinho, K; Nogueira, F; Reis, A; Silva-Pinto, A; Toscano, C	1
Davis, TME; Davis, WA; Hii, KC; Page-Sharp, M; Salman, S; Singh, B; Sugiarto, SR	1
Achan, J; Biculu, J; Bukoma, P; Ediamu, T; Gudoi, S; Mulebeke, R; Musiime, A; Nantanda, R; Tibenderana, JK; Tumwine, D; Wanzira, H	1
Asante, KP; Asiimwe, S; Barsainya, S; Boulton, C; Csermak Renner, K; Demin, I; Doumbia, S; Fofana, B; Gandhi, P; Grobusch, MP; Karita, E; Mugerwa, H; Ndayisaba, G; Oduro, A; Sayyed, S; Schmitt, EK; Straimer, J; Su, G; Venishetty, VK; Yeka, A	1
Ako, BA; Assi, SB; Coulibaly, B; Gbessi, EA; Gnondjui, A; Jambou, R; Koui, TS; Sanogo, I; Sokouri, DP; Tiacoh, NL; Toure, OA	1
Chapotera, G; Chirwa, T; D'Alessandro, U; Kazembe, L; Laufer, MK; Mathanga, D; Mukaka, M; Mwapasa, V; Patson, N	1
Assefa, DG; Makonnen, E; Yismaw, G	1
Abla, N; Barber, BE; Barnes, KI; Boyle, MJ; Chalon, S; Chughlay, MF; El Gaaloul, M; Engwerda, CR; Griffin, P; Kress, A; Marquart, L; McCarthy, JS; Möhrle, JJ; Reuter, SE; Schultz, HB; Tapley, P; van Giersbergen, P; Webster, RA; Wells, T	1
Gustafsson, L; James, S; Thozhuthumparambil, KP; Zhang, Y	1
Abuaku, B; Afriyie, PO; Bart-Plange, C; Duah-Quashie, NO; Ghansah, A; Gyasi, A; Koram, KA; Malm, KL; Owusu-Antwi, F; Quashie, N	1
Fike, A; Hocaoğlu, M; Katz, JD; Rajasimhan, S; Schiffenbauer, A	1
Aboh, PM; Adzemye, LM; Akam, LF; Ali, IM; Alifrangis, M; Ambani, MCE; Ango, Z; Bigoga, JD; Chedjou, JPK; Dinza, G; Dongmo, CH; Douanla, A; Ewane, MS; Fomboh, CT; Fosah, DA; Kotcholi, GB; Ludovic, AJ; Mbacham, WF; Moyeh, MN; Nana, WD; Ndikum, VN; Ngu, JA; Niba, PTN; Nji, AM; Nna, DRA; Oben, OLA; Omgba, PAM; Selly-Ngaloumo, AA; Tatah, FM; Ticha, JT	1
Apat, D; Carter, J; Igunza, P; Kimori, J; Kinyari, T; Kiplimo, R; Langat, B; Marita, E; Muhula, S	1
Baraka, V; Kamugisha, E; Kapesa, A; Kidenya, B; Konje, E; Marwa, K; Mukonzo, J; Swedberg, G	1
Amaratunga, C; Callery, JJ; Chau, NH; Chotivanich, K; Chotsiri, P; Day, NPJ; Dhorda, M; Dondorp, AM; Duanguppama, J; Dung, NTP; Hien, TT; Hoglund, RM; Imwong, M; Lek, D; Long, LT; Maude, RJ; Miotto, O; Mukaka, M; Nghia, HDT; Nguon, C; Peto, TJ; Rekol, H; Ruecker, A; Sokha, M; Sovann, Y; Tarning, J; Thuong, NTH; Tripura, R; van der Pluijm, RW; Van Luong, V; von Seidlein, L; Waithira, N; White, NJ	1
Das, S; Dhorda, M; Guérin, PJ; Imwong, M; Kebféné, M; Kérah-Hinzoumbé, C; Khomvarn, T; Nagorngar, TY; Saralamba, N; Sibley, CH; Srisutham, S; Vongpromek, R	1
Kweka, E; Mårtensson, A; Mmbando, BP; Msolo, D; Mwaiswelo, RO; Ngasala, B	1
Bauleni, A; Buchwald, AG; Chilombe, M; Coalson, JE; Cohee, LM; Laufer, MK; Mathanga, DP; Ngwira, A; Peterson, I; Schaffer-DeRoo, S; Seydel, KB; Taylor, TE; Valim, C; Wilson, ML	1
Bottieau, E; Huits, R; Rosanas-Urgell, A; Tournoy, TK; Van Esbroeck, M	1
Atieli, H; Debrah, I; Githeko, AK; Githure, J; Kazura, J; Lee, MC; Magomere, EO; Mukabana, WR; Ochwedo, KO; Olumeh, JO; Onyango, P; Otambo, WO; Ouma, C; Wang, C; Yan, G; Zhou, G	1
Asinya, M; Jeuronlon, MK; Kamara, P; Koko, VS; Kollie, A; Ma, L; Menard, D; Nyansaiye, P; Parwon, S; Pratt, OJ; Ringwald, P; Taweh, F; Tehmeh, L; Vonhm, B; Warsame, M	1
Basco, LK; Briolant, S; Casimiro, PN; Kobawila, SC; Matondo Diassivi, B; Ndounga, M; Pembet Singana, B; Ringwald, P; Youndouka, JM	1
Ashaba, FK; Edgar, K; Kamya, MR; Mwesigwa, S; Nsobya, SL; Ocan, M	1
Grundmann, O; Hernandez Maldonado, J	1
Balizou, O; Biago, U; Gody, JC; Moyen, M; Nambei, WS; Ndoua, C; Pounguinza, S	1
Batty, KT; Bwire, GM; Davis, TME; Makani, J; Manning, L; Minzi, OMS; Moore, BR; Ngasala, B; Page-Sharp, M; Salman, S; Sugiarto, SR	1
Baguiya, A; Barry, N; Burri, C; Dianda, F; Hien, D; Kaboré, JMT; Nombré, Y; Siribié, M; Sirima, SB; Soulama, I; Tchouatieu, AM; Tiono, AB	1
Hezagira, N; Riewpaiboon, A; Youngkong, S	1
Adeniji, OE; Amambua-Ngwa, A; Amawu, AU; Correa, S; Faal, F; Heinz, E; Hughes, G; Meremikwu, MM; Oboh, MA; Ogban, E	1
Obonyo, CO; Ogutu, BR	1
Amante, FH; Barber, BE; Birrell, GW; Edstein, MD; Gower, J; Heunis, J; Jennings, H; Llewellyn, S; Lynch, S; Marquart, L; McCarthy, JS; Mitchell, H; O'Neill, B; Peters, JM; Potter, AJ; Shanks, GD; Webster, R	1
Baguiya, A; Barry, N; Hien, D; Kaboré, JMT; Siribié, M; Sirima, SB; Soulama, I; Tchouatieu, AM; Tiono, AB	1
Abuom, D; Akala, HM; Andagalu, B; Chemwor, G; Cheruiyot, A; Cowden, J; Juma, D; Kamau, E; Ogutu, B; Okoth, R; Okudo, C; Onyango, I; Opot, B; Sifuna, P; Wafubwa, J; Watson, OJ; Yalwala, S; Yeda, R	1
Amambua-Ngwa, A; Bojang, F; D'Alessandro, U; Demba, MA; Diop, MF; Jeffries, D; Mane, K; Mbye, H; Mohammed, NI; Quashie, NB	1
Aguas, R; Boni, MF; Gao, B; Nguyen, TD; Okell, L; Penny, MA; Smith, DL; Tran, TN; Watson, OJ	1
Abdallah, KS; Bacar, A; Deng, C; Li, G; Li, M; Liu, R; Lu, C; Silai, R; Song, J; Tan, R; Wu, W; Xu, Q; Yuan, Y; Zhang, H; Zheng, S	1
Amambua-Ngwa, A; Dugassa, S; Golassa, L; Jaiteh, FK; Oboh, M; Oriero, E; Tadele, G	1
Buff, AM; Chebore, W; Desai, M; Kariuki, S; Otieno, K; Owidhi, M; Samuels, AM; Westercamp, N	1
Barnes, KI; Berghmans, PJ; Chalon, S; Chughlay, MF; El Gaaloul, M; Escoffier, E; Flynn, J; Gobeau, N; Izquierdo-Juncàs, D; Jansen, B; Kümmel, A; Marx, MW; Mitov, V; Möhrle, JJ; Rosanas-Urgell, A; Van Geertruyden, JP; Van Leuven, K	1
Chen, L; Cui, L; Guo, S; Huang, T; Huang, Y; Lu, F; Qian, J; Wang, B; Zhang, F	1
Kamugisha, E; Konje, ET; Liwa, AC; Marwa, KJ; Mwita, S; Swedberg, G	1
Aweeka, FT; Colt, M; Goodwin, J; Huang, L; Kajubi, R; Li, F; Mwebaza, N; Orukan, F; Parikh, S; Richards, K; Wang, K; Whalen, ME	1
Callery, JJ; Chotthanawathit, P; Conradis-Jansen, F; Dondorp, AM; Duanguppama, J; Ean, M; Heng, C; Imwong, M; Jongdeepaisal, M; Khonputsa, P; Madmanee, W; Maude, RJ; Mukaka, M; Peerawaranun, P; Pell, C; Peto, TJ; Pongsoipetch, K; Rekol, H; Sokha, M; Sovannaroth, S; Soviet, U; Tarning, J; Tripura, R; von Seidlein, L; Waithira, N; White, NJ	1
Dondorp, AM; Maude, RJ; Tarning, J; von Seidlein, L; White, NJ	1
Alemayehu, GS; Dinka, H; Golassa, L; Hassen, J	1
Aweeka, F; Ehrlich, H; Freeman, T; French, J; Goodwin, J; Huang, L; Kajubi, R; Kay, K; Li, F; Mwebaza, N; Ou, J; Parikh, S; Riggs, M; Ruiz-Garcia, A; Wade, M; Wang, K	1
Bibe, AF; Earland, DE; Ferrão, J; Novela, A; Searle, KM	1
Chenet, SM; Cortés, LJ; Guerra, AP; Lucchi, NW; Macedo de Oliveira, A; Olivera, MJ	1
Abuaku, B; Afrane, Y; Amoah, LE; Cui, L; Duah-Quashie, NO; Duan, M; Huang, Y; Li, X; Pan, M; Qin, Y; Sun, K; Wang, X; Yang, Q; Yang, Z; Zeng, W; Zhao, H; Zhao, W; Zhou, L; Zhu, W	1
Adegnika, AA; Akinosho, MA; Davi, SD; Dimessa-Mbadinga, LB; Handrich, C; Kreidenweiss, A; Kremsner, PG; Lell, B; Mombo-Ngoma, G; Ndzebe-Ndoumba, WF; Nordmann, T; Okwu, DG; Ramharter, M; Stelzl, D; Veletzky, L; Zoleko-Manego, R	1
Andrianaranjaka, VHI; Dodoson, BT; Fenomanana, J; Rakotoarisoa, MA; Ratsimbasoa, A	1
Augusto, O; Byamugisha, J; Clerk, C; Dellicour, S; Desai, M; Gomes, M; Guérin, PJ; Hill, J; Kagawa, M; Kariuki, S; Kisinza, W; Manyando, C; McGready, R; Mehta, U; Mosha, D; Mrema, S; Njunju, EM; Nosten, F; Rouamba, T; Rulisa, S; Saito, M; Sevene, E; Singlovic, J; Stepniewska, K; Stergachis, A; Ter Kuile, FO; Tinto, H; Vala, A; van Eijk, AM; Were, E; Yore, M	1
Abera, A; Alemayehu, BH; Anand, A; Assefa, A; Bekele, W; Dilu, D; Etana, K; Ezema, B; Girma, S; Haile, M; Hwang, J; Minta, AA; Mohammed, H; Moriarty, LF; Murphy, M; Sime, H; Solomon, H; Svigel, SS; Tadesse, M; Tadesse, Y; Tasew, G; Teka, H; Woyessa, A; Zhou, Z	1
Abongo, G; Basara, BB; Baseke, J; Bongo, GS; Day, NJP; Dhorda, M; Dondorp, AM; Fanello, C; Kayembe, DK; Maitland, K; Muhindo, R; Mukaka, M; Namayanja, C; Ndjowo, PO; Okalebo, CB; Olupot-Olupot, P; Onyamboko, MA; Onyas, P; Peerawaranun, P; Tarning, J; Taya, C; Taylor, WR; Titin, H; Uyoga, S; Waithira, N; Weere, W; Williams, TN	1
Falade, CO; Funwei, RI; Hammed, WA; Ojurongbe, O; Uyaiabasi, GN; Walker, O	1
Adedeji, WA; Dairo, MD; Fehintola, FA; Nguku, PM; Oyemakinde, A	1
Abay, SM; Assefa, A; Assefa, G; Bekele, W; Gidey, B; Gubae, K; Haile, M; Hailgiorgis, H; Mare, AK; Mohammed, H; Sime, H; Tasew, G	1
Adams, M; Buchwald, AG; Divala, TH; Earland, DE; Laufer, MK; Laurens, MB; Mallewa, JE; Miller, J; Mungwira, RG; Nampota-Nkomba, N; Nyangulu, W; Nyirenda, OM; Parikh, S; Plowe, CV; Taylor, TE; van Oosterhout, JJ	1
Mace, KE; Schultz, JS; Tan, KR	1
Abd-Rahman, AN; Barber, BE; Birrell, GW; Edstein, MD; Leelasena, I; Llewellyn, S; Marquart, L; McCarthy, JS; Moehrle, JJ; Potter, AJ; Sahai, N; Shanks, GD; Webster, R; Wesche, D	1
Adjei, GO; Ahorhorlu, SY; Alifrangis, M; Duah-Quashie, NO; Dzudzor, B; Hansson, H; Jensen, RW; Kudzi, W; Nartey, ET; Quashie, NB; Wang, CW; Zoiku, F	1
Adebayo, IA; Adeyemo, RO; Akinola, SA; Albert, O; Bwogo, P; John, O; Maniga, JN; Martin, O; Muchiri, JN; Onkoba, SK; Rael, M; Samuel, M; Sankarapandian, V; Wilberforce, M	1
Batty, KT; Davis, TME; Kasian, B; Laman, M; Lorry, L; Manning, L; Moore, BR; Pomat, W; Robinson, LJ; Salman, S; Tesine, P; Woon, SA; Yadi, G; Yambo, P	1
Ashton, RA; Bennett, A; Burnett, S; Eisele, TP; Hainsworth, M; Hamainza, B; Lungu, C; Miller, JM; Porter, T; Rutagwera, MI; Silumbe, K; Slater, H	1
Abala, C; Nyeko, R; Obiya, EM; Otim, F	1
Bogoch, II; Halani, S	1
Ahmed, RA; Begum, A; Hussain, SSA; Kalita, D; Kumar, A; Kumar, G; Shankar, H; Singh, K; Suri, HS; Swargiary, A	1
Akala, HM; Amwoma, JG; Andagalu, BM; Chemwor, GC; Cheruiyot, AC; Egbo, TE; Garges, EC; Juma, DW; Juma, JA; Kamau, E; Mwakio, EW; Ogutu, BR; Okoth, RO; Onyango, IA; Opot, BH; Roth, AL; Wakoli, DM; Watson, OJ; Yedah, RA	1
Aygen, B; Kalın Ünüvar, G; Türe, Z; Yaman, O; Yıldız, O	1
Djissem, PE; Manyeh, AK; Tetteh, JA	1
Aina, O; Awolola, ST; Babatunde, S; David, AN; Ekama, SO; Happi, CT; Ijezie, SN; Mohammed, AB; Mokuolu, O; Musa, AZ; Ogbulafor, N; Oguche, S; Okafor, H; Olukosi, AY; Ozor, L; Salako, BL; Uhomoibhi, PE; Wammanda, R	1
Adehossi, E; Arzika, II; Lamine, MM; Lobo, NF; Mahamadou, A; Mahmud, O; Maman Laminou, I; Sandrine, H; Sarr, D; Sarrasin-Hubert, V; Tidjani, IA	1
Adedapo, AD; Anjorin, OE; Falade, CO; Funwei, RI; Michael, OS; Mokuolu, OA; Olusanya, AL; Olusola, FI; Orimadegun, AE; Orimadegun, BE	1
Chepngetich, J; Gachie, B; Gathirwa, J; Kiboi, D; Kimani, F; Magoma, G; Muriithi, B; Mwitari, P; Onchieku, N; Thiong'o, K	1
Agyemang, SA; Aikins, M; Amon, S; Aryeetey, GC; Baabu, BS; Dwomoh, D; Malm, K; Nonvignon, J; Novignon, J; Owusu, R; Peprah, NY	1
Buzibye, A; Nakalembe, L; Nsobya, S; Ocan, M; Omali, D; Otike, C	1
Adebanjo, IM; Ademowo, OG; Ajayi, AM	1
Amambua-Ngwa, A; Dugassa, S; Golassa, L; Jawara, A; Oboh, M; Oriero, E; Tadele, G	1
Adhikari, B; Callery, JJ; Cheah, PY; Conradis-Jansen, F; Dondorp, AM; Ean, M; Jongdeepaisal, M; Khonputsa, P; Maude, RJ; Müller, O; Murgia, R; Pell, C; Peto, TJ; Sovannaroth, S; Tripura, R; von Seidlein, L	1
Bernieri, F; Cavallari, S; Doderer-Lang, C; Guidetti, C; L'Episcopia, M; Menard, D; Perrotti, E; Priuli, GB; Severini, C	1
Abel, L; Ambani, G; Boyce, M; Kirui, J; Laktabai, J; Malinga, J; Menya, D; Nalianya, E; Namae, J; O'Meara, W; Sang, E	1
Ayrık Demir, A; Erdoğan, E; Türe Yüce, Z; Yaman, O; Yıldız, O; Yürük, M	1
Aide, P; Baraka, V; Bassat, Q; Cousin, M; David, A; Gesase, S; Gwasupika, J; Hachizovu, S; Makenga, G; Manyando, C; Nhama, A; Ntizimira, CR; Obunge, O; Otsyula, N; Pathan, R; Risterucci, C; Su, G; Tshefu, KA	1
Aguas, R; Amaratunga, C; Boni, MF; Dhorda, M; Dondorp, AM; Gao, B; Nguyen, TD; Tran, TN; White, NJ	1
Abdelkader, O; Boulotigam, K; Djimadoum, M; Djimrassengar, H; Doderer-Lang, C; Hassoumi, M; Issa, AH; Issa, MS; Mahamat, MHT; Menard, D; Ndihiokubwayo, JB; Rasmussen, C; Saleh, IDM; Warsame, M	1
Bauserman, M; Laktabai, J; Rent, S; Taylor, SM; Tshefu, AK	1
Dellicour, S; Gutman, JR; Hill, J; Ochodo, E; Osoro, CB; Ter Kuile, F; Young, T	1
Dellicour, S; Gutman, JR; Hill, J; Ochodo, E; Osoro, CB; Ter Kuile, FO; Young, T	1
Boni, MF; Kabera, M; Li, H; Ngabonziza, JCS; Nguyen, TD; Tran, KT; Tran, TN; Uwimana, A; Zupko, RJ	1
Cai, J; Chen, G; Hu, G; Jin, L; Li, J; Li, Q; Li, S; Li, Y; Qian, J; Zhang, X; Zhou, Q	1
Ahmed, K; Culleton, R; Dony, JJF; Fornace, KM; Habil, B; Hassan, MR; Hod, R; Ibrahim, SSA; Jantim, A; Jeffree, MS; Jiee, SF; Mohamed, AFB; Naserrudin, NA	1
D'Alessandro, U; Dabira, ED; Diakite, H; Djimde, M; Dorlo, TP; Erhart, A; González, R; Kabore, B; Kayentao, K; Keita, M; Macuacua, S; Menendez, C; Mens, P; Muhindo, HM; Piqueras, M; Sagara, I; Schallig, H; Sevene, E; Tinto, H; Traore, M; Tshiongo, JK; Vala, A	1
Abade, A; O'Meara, WP; Odhiambo, F; Odhiambo, FO; Owiny, M; Oyugi, EO	1
Bamisaiye, A; Basara, BB; Baseke, J; Day, NPJ; Fanello, C; Kayembe, DK; Maitland, K; Muhindo, R; Mukaka, M; Namayanja, C; Ndjowo, PO; Okalebo, CB; Olupot-Olupot, P; Onyamboko, MA; Onyas, P; Taya, C; Taylor, WRJ; Titin, H; Uyoga, S; Were, W; Williams, TN	1
Acharya, S; Arnold, L; Chico, RM; Gore-Langton, GR; Lufele, E; Moore, BR; Price, RN; Rogerson, SJ; Ter Kuile, FO; Thriemer, K; Unger, HW; van Eijk, AM; Wu, C	1
Ahoua Alou, LP; Camara, S; Koffi, AA; N'Guessan, B; N'Guessan, R; Oumbouke, WA; Rowland, M; Thomas, MB; Tia, IZ; Wolie, RZ; Zoh, MG	1
Abate, DT; Alam, MS; Anose, RT; Baird, JK; Christian, M; Degaga, TS; Ekawati, LL; Hailu, A; Hossain, MS; Karahalios, A; Kibria, MG; Kiros, FG; Lee, G; Ley, B; Mnjala, H; Panggalo, LV; Price, RN; Rajasekhar, M; Rumaseb, A; Sadhewa, A; Satyagraha, AW; Simpson, JA; Sutanto, I; Tego, TT; Thriemer, K; Weston, S; Woyessa, A	1

Reviews

9 review(s) available for artemether and cgp-56697

Article	Year
Artemisinin--an innovative cornerstone for anti-malaria therapy. Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques, 2008, Volume: 66 Topics: Animals; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisia annua; Artemisinins; Biomass; Crops, Agricultural; Drug Combinations; Drug Design; Drug Resistance; Drugs, Chinese Herbal; Ethanolamines; Fluorenes; Humans; Malaria; Models, Molecular; Molecular Structure; Technology, Pharmaceutical; Treatment Outcome	2008
Efficacy of Single-Dose Primaquine With Artemisinin Combination Therapy on Plasmodium falciparum Gametocytes and Transmission: An Individual Patient Meta-Analysis. The Journal of infectious diseases, 2022, 04-01, Volume: 225, Issue:7 Topics: Animals; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Humans; Malaria, Falciparum; Plasmodium falciparum; Primaquine	2022
Drug treatment and prevention of malaria in pregnancy: a critical review of the guidelines. Malaria journal, 2021, Jan-23, Volume: 20, Issue:1 Topics: Adult; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artesunate; Chloroquine; Drug Combinations; Female; Humans; Malaria; Parasitemia; Practice Guidelines as Topic; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Quinine; Sulfadoxine	2021
Comparative effect of dihydroartemisinin-piperaquine and artemether-lumefantrine on gametocyte clearance and haemoglobin recovery in children with uncomplicated Plasmodium falciparum malaria in Africa: a systematic review and meta-analysis of randomized c International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2021, Volume: 113 Topics: Africa; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Drug Combinations; Fluorenes; Hemoglobins; Humans; Malaria, Falciparum; Plasmodium falciparum; Quinolines; Randomized Controlled Trials as Topic	2021
Therapeutic efficacy of artemether-lumefantrine, artesunate-amodiaquine and dihydroartemisinin-piperaquine in the treatment of uncomplicated Plasmodium falciparum malaria in Sub-Saharan Africa: A systematic review and meta-analysis. PloS one, 2022, Volume: 17, Issue:3 Topics: Africa South of the Sahara; Amodiaquine; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Drug Combinations; Ethanolamines; Humans; Malaria; Malaria, Falciparum; Piperazines; Plasmodium falciparum; Quinolines	2022
Temporal distribution of Plasmodium falciparum recrudescence following artemisinin-based combination therapy: an individual participant data meta-analysis. Malaria journal, 2022, Mar-24, Volume: 21, Issue:1 Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Humans; Plasmodium falciparum; Recurrence	2022
Drug-Drug Interactions of Artemisinin-Based Combination Therapies in Malaria Treatment: A Narrative Review of the Literature. Journal of clinical pharmacology, 2022, Volume: 62, Issue:10 Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Drug Combinations; Drug Interactions; Drug Therapy, Combination; Humans; Malaria; Malaria, Falciparum	2022
Pregnancy outcomes after first-trimester treatment with artemisinin derivatives versus non-artemisinin antimalarials: a systematic review and individual patient data meta-analysis. Lancet (London, England), 2023, 01-14, Volume: 401, Issue:10371 Topics: Abortion, Spontaneous; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Drug Combinations; Ethanolamines; Female; Humans; Malaria; Malaria, Falciparum; Pregnancy; Pregnancy Outcome; Pregnancy Trimester, First; Prospective Studies; Quinine; Stillbirth	2023
The effect and control of malaria in pregnancy and lactating women in the Asia-Pacific region. The Lancet. Global health, 2023, Volume: 11, Issue:11 Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Asia; Female; Humans; Lactation; Malaria; Malaria, Falciparum; Pregnancy	2023

Trials

40 trial(s) available for artemether and cgp-56697

Article	Year
A randomized controlled trial of artemether/benflumetol, a new antimalarial and pyrimethamine/sulfadoxine in the treatment of uncomplicated falciparum malaria in African children. The American journal of tropical medicine and hygiene, 1998, Volume: 58, Issue:5 Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Child, Preschool; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male; Pyrimethamine; Sesquiterpenes; Sulfadoxine	1998
Efficacy and safety of CGP 56697 (artemether and benflumetol) compared with chloroquine to treat acute falciparum malaria in Tanzanian children aged 1-5 years. Tropical medicine & international health : TM & IH, 1998, Volume: 3, Issue:6 Topics: Acute Disease; Administration, Oral; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Child, Preschool; Chloroquine; Drug Administration Schedule; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male; Sesquiterpenes; Tanzania; Treatment Outcome	1998
Population pharmacokinetics and therapeutic response of CGP 56697 (artemether + benflumetol) in malaria patients. British journal of clinical pharmacology, 1998, Volume: 46, Issue:6 Topics: Adolescent; Adult; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Double-Blind Method; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria; Male; Middle Aged; Sesquiterpenes; Treatment Outcome	1998
Pharmacokinetics of benflumetol given as a fixed combination artemether-benflumetol (CGP 56697) in Thai patients with uncomplicated falciparum malaria. International journal of clinical pharmacology research, 1999, Volume: 19, Issue:2 Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Drug Combinations; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Random Allocation; Sesquiterpenes; Thailand; Time Factors	1999
Cardiac effects of co-artemether (artemether/lumefantrine) and mefloquine given alone or in combination to healthy volunteers. European journal of clinical pharmacology, 2000, Volume: 56, Issue:5 Topics: Adult; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Chromatography, High Pressure Liquid; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Drug Interactions; Electrocardiography; Ethanolamines; Fluorenes; Heart; Humans; Male; Mefloquine; Middle Aged; Sesquiterpenes	2000
Safety and tolerability of artemether-lumefantrine versus dihydroartemisinin-piperaquine for malaria in young HIV-infected and uninfected children. Malaria journal, 2009, Nov-30, Volume: 8 Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Follow-Up Studies; HIV Infections; Humans; Infant; Longitudinal Studies; Malaria, Falciparum; Male; Quinolines; Risk Factors; Treatment Outcome; Uganda	2009
Therapeutic efficacy and effect on gametocyte carriage of an artemisinin and a non-based combination treatment in children with uncomplicated P. falciparum malaria, living in an area with high-level chloroquine resistance. Journal of tropical pediatrics, 2010, Volume: 56, Issue:6 Topics: Amodiaquine; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Follow-Up Studies; Gametogenesis; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male; Nigeria; Plasmodium falciparum; Polymerase Chain Reaction; Pyrimethamine; Sulfalene; Treatment Outcome	2010
Similar efficacy and safety of artemether-lumefantrine (Coartem®) in African infants and children with uncomplicated falciparum malaria across different body weight ranges. Malaria journal, 2011, Dec-16, Volume: 10 Topics: Age Factors; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Body Weight; Child; Child, Preschool; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male; Plasmodium falciparum; Polymerase Chain Reaction; Time Factors; Treatment Outcome	2011
Therapeutic efficacy of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in northwest Benin. Malaria journal, 2016, Jan-22, Volume: 15 Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Benin; Child, Preschool; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male	2016
Can Rapid Diagnostic Testing for Malaria Increase Adherence to Artemether-Lumefantrine?: A Randomized Controlled Trial in Uganda. The American journal of tropical medicine and hygiene, 2016, Volume: 94, Issue:4 Topics: Adult; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria; Male; Medication Adherence; Point-of-Care Testing; Uganda	2016
A Randomized Controlled Trial of Three- versus Five-Day Artemether-Lumefantrine Regimens for Treatment of Uncomplicated Plasmodium falciparum Malaria in Pregnancy in Africa. Antimicrobial agents and chemotherapy, 2020, 02-21, Volume: 64, Issue:3 Topics: Adult; Africa; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Female; Humans; Malaria, Falciparum; Pregnancy; Young Adult	2020
Randomized Controlled Trial of the Electrocardiographic Effects of Four Antimalarials for Pregnant Women with Uncomplicated Malaria on the Thailand-Myanmar Border. Antimicrobial agents and chemotherapy, 2021, 03-18, Volume: 65, Issue:4 Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Drug Therapy, Combination; Electrocardiography; Female; Humans; Malaria; Malaria, Falciparum; Myanmar; Pregnancy; Pregnant Women; Quinolines; Thailand	2021
Efficacy and safety of artesuante-amodiaquine and artemether lumefantrine, the first line malaria treatment in six sentinel's sites of Côte d'Ivoire, West Africa. Annals of parasitology, 2020, Volume: 66, Issue:4 Topics: Amodiaquine; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Cote d'Ivoire; Drug Combinations; Ethanolamines; Fluorenes; Humans; Infant; Malaria; Malaria, Falciparum; Treatment Outcome	2020
A randomized controlled trial of dihydroartemisinin-piperaquine, artesunate-mefloquine and extended artemether-lumefantrine treatments for malaria in pregnancy on the Thailand-Myanmar border. BMC medicine, 2021, 06-10, Volume: 19, Issue:1 Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Drug Therapy, Combination; Female; Humans; Infant, Newborn; Malaria; Malaria, Falciparum; Mefloquine; Myanmar; Pregnancy; Premature Birth; Quinolines; Thailand	2021
Effectiveness and safety of reactive focal mass drug administration (rfMDA) using dihydroartemisinin-piperaquine to reduce malaria transmission in the very low-endemic setting of Eswatini: a pragmatic cluster randomised controlled trial. BMJ global health, 2021, Volume: 6, Issue:6 Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Eswatini; Humans; Malaria; Mass Drug Administration; Quinolines	2021
High Prevalence of Plasmodium falciparum K13 Mutations in Rwanda Is Associated With Slow Parasite Clearance After Treatment With Artemether-Lumefantrine. The Journal of infectious diseases, 2022, 04-19, Volume: 225, Issue:8 Topics: Animals; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Drug Resistance; Gabon; Humans; Malaria, Falciparum; Mutation; Parasites; Plasmodium falciparum; Prevalence; Protozoan Proteins; Rwanda	2022
Study protocol: an open-label individually randomised controlled trial to assess the efficacy of artemether-lumefantrine prophylaxis for malaria among forest goers in Cambodia. BMJ open, 2021, 07-07, Volume: 11, Issue:7 Topics: Adult; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Cambodia; Forests; Humans; Malaria; Malaria, Falciparum; Randomized Controlled Trials as Topic; Treatment Outcome	2021
Efficacy of Cipargamin (KAE609) in a Randomized, Phase II Dose-Escalation Study in Adults in Sub-Saharan Africa With Uncomplicated Plasmodium falciparum Malaria. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2022, 05-30, Volume: 74, Issue:10 Topics: Adult; Africa South of the Sahara; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Drug Combinations; Ethanolamines; Fluorenes; Humans; Indoles; Malaria, Falciparum; Plasmodium falciparum; Spiro Compounds; Treatment Outcome	2022
Joint modelling of multivariate longitudinal clinical laboratory safety outcomes, concomitant medication and clinical adverse events: application to artemisinin-based treatment during pregnancy clinical trial. BMC medical research methodology, 2021, 10-09, Volume: 21, Issue:1 Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Female; Humans; Laboratories; Malaria, Falciparum; Pregnancy	2021
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Coadministered Ruxolitinib and Artemether-Lumefantrine in Healthy Adults. Antimicrobial agents and chemotherapy, 2022, 01-18, Volume: 66, Issue:1 Topics: Adolescent; Adult; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Male; Middle Aged; Nitriles; Pyrazoles; Pyrimidines; Single-Blind Method; Young Adult	2022
Effectiveness and safety of artesunate-amodiaquine versus artemether-lumefantrine for home-based treatment of uncomplicated Plasmodium falciparum malaria among children 6-120 months in Yaoundé, Cameroon: a randomized trial. BMC infectious diseases, 2022, Feb-21, Volume: 22, Issue:1 Topics: Amodiaquine; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Cameroon; Child; Drug Combinations; Ethanolamines; Humans; Infant; Malaria, Falciparum; Plasmodium falciparum; Treatment Outcome	2022
Triple therapy with artemether-lumefantrine plus amodiaquine versus artemether-lumefantrine alone for artemisinin-resistant, uncomplicated falciparum malaria: an open-label, randomised, multicentre trial. The Lancet. Infectious diseases, 2022, Volume: 22, Issue:6 Topics: Amodiaquine; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Malaria; Malaria, Falciparum; Male; Plasmodium falciparum; Recurrence; Vomiting	2022
Artemisinin-piperaquine versus artemether-lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Grande Comore island: an open-label, non-randomised controlled trial. International journal of antimicrobial agents, 2022, Volume: 60, Issue:4 Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Drug Combinations; Ethanolamines; Fluorenes; Humans; Malaria; Malaria, Falciparum; Piperazines; Plasmodium falciparum; Quinolines	2022
Safety, Tolerability, and Parasite Clearance Kinetics in Controlled Human Malaria Infection after Direct Venous Inoculation of Plasmodium falciparum Sporozoites: A Model for Evaluating New Blood-Stage Antimalarial Drugs. The American journal of tropical medicine and hygiene, 2022, 10-12, Volume: 107, Issue:4 Topics: Adult; Animals; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Humans; Malaria; Parasitemia; Parasites; Plasmodium falciparum; Sporozoites	2022
The Impact of Extended Treatment With Artemether-lumefantrine on Antimalarial Exposure and Reinfection Risks in Ugandan Children With Uncomplicated Malaria: A Randomized Controlled Trial. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2023, 02-08, Volume: 76, Issue:3 Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Drug Combinations; Ethanolamines; Fluorenes; Humans; Infant; Lumefantrine; Malaria; Malaria, Falciparum; Parasitemia; Prospective Studies; Reinfection; Uganda	2023
Antimalarial chemoprophylaxis for forest goers in southeast Asia: an open-label, individually randomised controlled trial. The Lancet. Infectious diseases, 2023, Volume: 23, Issue:1 Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Cambodia; Chemoprevention; Drug Combinations; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria; Malaria, Falciparum	2023
Modelling the optimal dosing schedule for artemether-lumefantrine chemoprophylaxis against malaria. BMC research notes, 2022, Oct-02, Volume: 15, Issue:1 Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Chemoprevention; Drug Combinations; Ethanolamines; Fluorenes; Humans; Malaria; Malaria, Falciparum	2022
Effectiveness of antimalarial drug combinations in treating concomitant urogenital schistosomiasis in malaria patients in Lambaréné, Gabon: A non-randomised event-monitoring study. PLoS neglected tropical diseases, 2022, Volume: 16, Issue:10 Topics: Amodiaquine; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artesunate; Drug Combinations; Ethanolamines; Gabon; Humans; Malaria; Malaria, Falciparum; Schistosomiasis haematobia	2022
Comparative effect of artemether-lumefantrine and artesunate-amodiaquine on gametocyte clearance in children with uncomplicated Plasmodium falciparum malaria in Madagascar. Malaria journal, 2022, Nov-14, Volume: 21, Issue:1 Topics: Adolescent; Amodiaquine; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artesunate; Child; Child, Preschool; Drug Combinations; Ethanolamines; Humans; Infant; Madagascar; Malaria, Falciparum; Plasmodium falciparum	2022
Therapeutic efficacies of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum and chloroquine and dihydroartemisinin-piperaquine for uncomplicated Plasmodium vivax infection in Ethiopia. Malaria journal, 2022, Dec-01, Volume: 21, Issue:1 Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Chloroquine; Ethiopia; Humans; Malaria, Falciparum; Malaria, Vivax; Plasmodium falciparum; Plasmodium vivax	2022
Safety of age-dosed, single low-dose primaquine in children with glucose-6-phosphate dehydrogenase deficiency who are infected with Plasmodium falciparum in Uganda and the Democratic Republic of the Congo: a randomised, double-blind, placebo-controlled, n The Lancet. Infectious diseases, 2023, Volume: 23, Issue:4 Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Child; Democratic Republic of the Congo; Female; Glucosephosphate Dehydrogenase; Glucosephosphate Dehydrogenase Deficiency; Hemoglobins; Humans; Infant; Malaria, Falciparum; Male; Plasmodium falciparum; Primaquine; Uganda; World Health Organization	2023
Artemether-lumefantrine efficacy among adults on antiretroviral therapy in Malawi. Malaria journal, 2023, Jan-27, Volume: 22, Issue:1 Topics: Adult; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Drug Combinations; Ethanolamines; Fluorenes; HIV Infections; Humans; Lumefantrine; Malaria; Malaria, Falciparum; Malawi; Treatment Outcome	2023
Ultra-short course, high-dose primaquine to prevent Plasmodium vivax infection following uncomplicated pediatric malaria: A randomized, open-label, non-inferiority trial of early versus delayed treatment. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2023, Volume: 130 Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Child; Humans; Malaria; Malaria, Falciparum; Malaria, Vivax; Parasitemia; Plasmodium vivax; Primaquine; Time-to-Treatment	2023
Therapeutic response to artemisinin combination therapies among individuals with Plasmodium falciparum single infection vs mixed Plasmodium species infections: a retrospective posthoc analysis in Kisumu County, western Kenya. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2023, Volume: 132 Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Drug Combinations; Humans; Kenya; Malaria; Malaria, Falciparum; Plasmodium falciparum; Quinolines; Reinfection; Retrospective Studies	2023
Efficacy and safety of pyronaridine-artesunate versus artemether-lumefantrine in the treatment of acute uncomplicated malaria in children in South-West Nigeria: an open-labelled randomized controlled trial. Malaria journal, 2023, May-13, Volume: 22, Issue:1 Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Infant; Malaria, Falciparum; Male; Nigeria; Retrospective Studies; Treatment Outcome	2023
Community engagement among forest goers in a malaria prophylaxis trial: implementation challenges and implications. Malaria journal, 2023, Jun-08, Volume: 22, Issue:1 Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Female; Forests; Humans; Malaria	2023
Supply-side and demand-side factors influencing uptake of malaria testing services in the community: lessons for scale-up from a post-hoc analysis of a cluster randomised, community-based trial in western Kenya. BMJ open, 2023, 06-26, Volume: 13, Issue:6 Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Community Health Services; Community Health Workers; Fever; Humans; Kenya; Malaria; Research Design	2023
Efficacy and safety of pyronaridine-artesunate (PYRAMAX) for the treatment of BMJ open, 2023, 10-09, Volume: 13, Issue:10 Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Clinical Trials, Phase III as Topic; Drug Combinations; Female; Humans; Infant; Malaria; Malaria, Falciparum; Pregnancy; Pregnant Women; Randomized Controlled Trials as Topic; Sub-Saharan African People; Treatment Outcome	2023
Factors affecting haemoglobin dynamics in African children with acute uncomplicated Plasmodium falciparum malaria treated with single low-dose primaquine or placebo. BMC medicine, 2023, 10-20, Volume: 21, Issue:1 Topics: alpha-Thalassemia; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Child; Child, Preschool; Female; Glucosephosphate Dehydrogenase Deficiency; Hemoglobins; Humans; Malaria, Falciparum; Male; Plasmodium falciparum; Primaquine	2023
Primaquine radical cure in patients with Plasmodium falciparum malaria in areas co-endemic for P falciparum and Plasmodium vivax (PRIMA): a multicentre, open-label, superiority randomised controlled trial. Lancet (London, England), 2023, Dec-02, Volume: 402, Issue:10417 Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Australia; Humans; Malaria; Malaria, Falciparum; Malaria, Vivax; Parasitemia; Plasmodium falciparum; Plasmodium vivax; Primaquine	2023

Other Studies

93 other study(ies) available for artemether and cgp-56697

Article	Year
Changes in antioxidant status and biochemical indices after acute administration of artemether, artemether-lumefantrine and halofantrine in rats. Basic & clinical pharmacology & toxicology, 2008, Volume: 102, Issue:4 Topics: Administration, Oral; Alanine Transaminase; Animals; Antimalarials; Antioxidants; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Aspartate Aminotransferases; Bilirubin; Biomarkers; Blood Urea Nitrogen; Catalase; Creatinine; Drug Combinations; Ethanolamines; Fluorenes; Glutathione; Glutathione Transferase; Intubation, Gastrointestinal; Kidney; Lipid Peroxidation; Liver; Male; Phenanthrenes; Rats; Rats, Wistar; Superoxide Dismutase; Time Factors	2008
Pharmacokinetics of artemether and dihydroartemisinin in healthy Pakistani male volunteers treated with artemether-lumefantrine. Malaria journal, 2010, Oct-11, Volume: 9 Topics: Administration, Oral; Adult; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Chromatography, Liquid; Drug Combinations; Ethanolamines; Fluorenes; Human Experimentation; Humans; Male; Middle Aged; Pakistan; Plasma; Tandem Mass Spectrometry; Time Factors	2010
The effect of lopinavir/ritonavir on the antimalarial activity of artemether or artemether/lumefantrine in a mouse model of Plasmodium berghei. Journal of chemotherapy (Florence, Italy), 2015, Volume: 27, Issue:1 Topics: Animals; Anti-Retroviral Agents; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Coinfection; Disease Models, Animal; Drug Combinations; Drug Interactions; Ethanolamines; Fluorenes; HIV Infections; Lopinavir; Malaria; Mice; Plasmodium berghei; Ritonavir	2015
Baseline in vivo, ex vivo and molecular responses of Plasmodium falciparum to artemether and lumefantrine in three endemic zones for malaria in Colombia. Transactions of the Royal Society of Tropical Medicine and Hygiene, 2017, 02-01, Volume: 111, Issue:2 Topics: Adolescent; Adult; Aged; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Colombia; DNA Copy Number Variations; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria; Male; Middle Aged; Parasitemia; Plasmodium falciparum; Polymorphism, Genetic; Protozoan Proteins; Young Adult	2017
Evaluation of the effects on the QT-interval of 4 artemisinin-based combination therapies with a correction-free and heart rate-free method. Scientific reports, 2019, 01-29, Volume: 9, Issue:1 Topics: Adolescent; Amodiaquine; Antimalarials; Arrhythmias, Cardiac; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Drug Combinations; Ethanolamines; Female; Fluorenes; Heart Rate; Humans; Long QT Syndrome; Malaria; Malaria, Falciparum; Male; Quinolines; Young Adult	2019
Interpretation of Drug Interactions between Dolutegravir and Artemether-Lumefantrine or Artesunate-Amodiaquine. Antimicrobial agents and chemotherapy, 2019, Volume: 63, Issue:6 Topics: Amodiaquine; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artesunate; Drug Interactions; Heterocyclic Compounds, 3-Ring; Oxazines; Piperazines; Pyridones	2019
Reply to Banda et al., "Interpretation of Drug Interactions between Dolutegravir and Artemether-Lumefantrine or Artesunate-Amodiaquine". Antimicrobial agents and chemotherapy, 2019, Volume: 63, Issue:6 Topics: Amodiaquine; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artesunate; Drug Interactions; Heterocyclic Compounds, 3-Ring; Oxazines; Piperazines; Pyridones	2019
[The treatment of malaria]. Nederlands tijdschrift voor geneeskunde, 2019, 05-24, Volume: 163 Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Chloroquine; Drug Combinations; Drug Therapy, Combination; Female; Humans; Malaria; Malaria Vaccines; Male; Netherlands; Pregnancy; Travel	2019
Adherence to antimalarial drug policy among doctors in Delta State, Nigeria: implications for malaria control. Ghana medical journal, 2019, Volume: 53, Issue:2 Topics: Adult; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artesunate; Chloroquine; Drug Resistance, Microbial; Female; Guideline Adherence; Health Policy; Humans; Malaria, Falciparum; Male; Middle Aged; Nigeria; Plasmodium falciparum; Practice Guidelines as Topic; Practice Patterns, Physicians'; Quinine; Surveys and Questionnaires; Young Adult	2019
Safety and tolerability of artesunate-amodiaquine, artemether-lumefantrine and quinine plus clindamycin in the treatment of uncomplicated Plasmodium falciparum malaria in Kinshasa, the Democratic Republic of the Congo. PloS one, 2019, Volume: 14, Issue:9 Topics: Amodiaquine; Anti-Bacterial Agents; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Child, Preschool; Clindamycin; Democratic Republic of the Congo; Drug Combinations; Female; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male; Plasmodium falciparum; Quinine	2019
Differential Impact of Nevirapine on Artemether-Lumefantrine Pharmacokinetics in Individuals Stratified by Antimicrobial agents and chemotherapy, 2020, 02-21, Volume: 64, Issue:3 Topics: Artemether; Artemether, Lumefantrine Drug Combination; Cytochrome P-450 CYP2B6; Genotype; HIV; Nevirapine; Polymorphism, Genetic	2020
Efavirenz-Based Antiretroviral Therapy Reduces Artemether-Lumefantrine Exposure for Malaria Treatment in HIV-Infected Pregnant Women. Journal of acquired immune deficiency syndromes (1999), 2020, 02-01, Volume: 83, Issue:2 Topics: Adolescent; Adult; Alkynes; Anti-HIV Agents; Anti-Retroviral Agents; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Benzoxazines; Cyclopropanes; Drug Combinations; Drug Interactions; Female; HIV Infections; Humans; Lumefantrine; Malaria; Malaria, Falciparum; Pregnancy; Prospective Studies; Uganda; Young Adult	2020
Plasmodium falciparum Isolates Carrying Antimicrobial agents and chemotherapy, 2020, 07-22, Volume: 64, Issue:8 Topics: Alleles; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Cross-Sectional Studies; Drug Resistance; Humans; Indonesia; Malaria, Falciparum; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Protozoan Proteins	2020
Case report: recurrence of Plasmodium vivax malaria due to defective cytochrome P450 2D6 function in Pos Lenjang, Pahang, Malaysia. Transactions of the Royal Society of Tropical Medicine and Hygiene, 2020, 09-01, Volume: 114, Issue:9 Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Child; Cytochrome P-450 CYP2D6; Humans; Malaria, Vivax; Malaysia; Plasmodium vivax; Primaquine; Recurrence	2020
Teratogen update: Malaria in pregnancy and the use of antimalarial drugs in the first trimester. Birth defects research, 2020, Volume: 112, Issue:18 Topics: Animals; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Female; Malaria; Placenta; Pregnancy; Rabbits; Rats; Teratogens	2020
Self-medication practice with antimalarials & the determinants of malaria treatment-seeking behavior among postpartum mothers in a rural community in Nigeria. Pharmacoepidemiology and drug safety, 2021, Volume: 30, Issue:4 Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Cross-Sectional Studies; Female; Humans; Infant, Newborn; Malaria; Mothers; Nigeria; Postpartum Period; Rural Population	2021
Dolutegravir pharmacokinetics during co-administration with either artemether/lumefantrine or artesunate/amodiaquine. The Journal of antimicrobial chemotherapy, 2021, 04-13, Volume: 76, Issue:5 Topics: Africa; Amodiaquine; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artesunate; Drug Combinations; Ethanolamines; Fluorenes; Heterocyclic Compounds, 3-Ring; Humans; Malaria, Falciparum; Oxazines; Piperazines; Pyridones	2021
Protocol for a quasi-experimental study to assess the feasibility, acceptability and costs of multiple first-lines artemisinin-based combination therapies for uncomplicated malaria in the Kaya health district, Burkina Faso. BMJ open, 2021, 02-15, Volume: 11, Issue:2 Topics: Amodiaquine; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Burkina Faso; Child; Child, Preschool; Cross-Sectional Studies; Drug Combinations; Feasibility Studies; Female; Humans; Malaria; Malaria, Falciparum; Pregnancy	2021
Electrocardiographic effect of artemisinin-piperaquine, dihydroartemisinin-piperaquine, and artemether-lumefantrine treatment in falciparum malaria patients. Revista da Sociedade Brasileira de Medicina Tropical, 2021, Volume: 54 Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Drug Combinations; Electrocardiography; Humans; Malaria; Malaria, Falciparum; Quinolines	2021
Reply to Rasmussen and Ringwald, "Continued Low Efficacy of Artemether-Lumefantrine in Angola?" Antimicrobial agents and chemotherapy, 2021, 05-18, Volume: 65, Issue:6 Topics: Angola; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Humans; Malaria, Falciparum	2021
Continued Low Efficacy of Artemether-Lumefantrine in Angola? Antimicrobial agents and chemotherapy, 2021, 05-18, Volume: 65, Issue:6 Topics: Angola; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Lumefantrine	2021
Antimalarial drug resistance markers in human immunodeficiency virus (HIV)-positive and HIV-negative adults with asymptomatic malaria infections in Port Harcourt, Nigeria. Transactions of the Royal Society of Tropical Medicine and Hygiene, 2021, 05-08, Volume: 115, Issue:5 Topics: Adult; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Drug Combinations; Drug Resistance; HIV; Humans; Malaria; Malaria, Falciparum; Nigeria; Plasmodium falciparum; Protozoan Proteins	2021
Persistent Submicroscopic Plasmodium falciparum Parasitemia 72 Hours after Treatment with Artemether-Lumefantrine Predicts 42-Day Treatment Failure in Mali and Burkina Faso. Antimicrobial agents and chemotherapy, 2021, 07-16, Volume: 65, Issue:8 Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Burkina Faso; Drug Combinations; Ethanolamines; Humans; Malaria, Falciparum; Mali; Parasitemia; Plasmodium falciparum; Treatment Failure	2021
Novel Dipeptides Bearing Sulfonamide as Antimalarial and Antitrypanosomal Agents: Synthesis and Molecular Docking. Medicinal chemistry (Shariqah (United Arab Emirates)), 2022, Volume: 18, Issue:3 Topics: Animals; Antimalarials; Antiprotozoal Agents; Artemether; Artemether, Lumefantrine Drug Combination; Dipeptides; Mice; Molecular Docking Simulation; Parasitic Sensitivity Tests; Structure-Activity Relationship; Sulfonamides	2022
Artemether-lumefantrine treatment failure of uncomplicated Plasmodium falciparum malaria in travellers coming from Angola and Mozambique. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2021, Volume: 110 Topics: Angola; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Humans; Malaria, Falciparum; Male; Middle Aged; Mozambique; Plasmodium falciparum; Treatment Failure	2021
The pharmacokinetic properties of artemether and lumefantrine in Malaysian patients with Plasmodium knowlesi malaria. British journal of clinical pharmacology, 2022, Volume: 88, Issue:2 Topics: Adult; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria; Malaria, Falciparum; Male; Middle Aged; Plasmodium knowlesi	2022
An assessment of the knowledge, practices and resources during the delivery of malaria health care services among private health care practitioners: a cross section study in the Mid-Western Region of Uganda. BMC health services research, 2021, Aug-10, Volume: 21, Issue:1 Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Cross-Sectional Studies; Delivery of Health Care; Health Facilities; Humans; Malaria; Private Sector; Uganda	2021
Artemisinin derivative-containing therapies and abnormal hemoglobin: Do we need to adapt the treatment? Parasite (Paris, France), 2021, Volume: 28 Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Cote d'Ivoire; Drug Combinations; Ethanolamines; Hemoglobins, Abnormal; Humans; Malaria, Falciparum; Plasmodium falciparum; Retrospective Studies; Treatment Outcome	2021
Fatal case of delayed-onset haemolytic anaemia after oral artemether-lumefantrine. BMJ case reports, 2021, Nov-19, Volume: 14, Issue:11 Topics: Anemia, Hemolytic; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Drug Combinations; Female; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Middle Aged	2021
Trends and predictive factors for treatment failure following artemisinin-based combination therapy among children with uncomplicated malaria in Ghana: 2005-2018. BMC infectious diseases, 2021, Dec-15, Volume: 21, Issue:1 Topics: Amodiaquine; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Drug Combinations; Ghana; Humans; Infant; Malaria; Malaria, Falciparum; Treatment Failure	2021
Report of a Homeopathic Medication Regimen Containing Artemether/Lumefantrine in a Patient With Rheumatoid Arthritis. Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2021, Dec-01, Volume: 27, Issue:8S Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Arthritis, Rheumatoid; Humans; Lumefantrine	2021
Implementation of community case management of malaria in malaria endemic counties of western Kenya: are community health volunteers up to the task in diagnosing malaria? Malaria journal, 2022, Mar-05, Volume: 21, Issue:1 Topics: Adult; Aged; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Case Management; Community Health Workers; Diagnostic Tests, Routine; Female; Humans; Kenya; Malaria; Middle Aged; Public Health; Volunteers	2022
Molecular surveillance for operationally relevant genetic polymorphisms in Plasmodium falciparum in Southern Chad, 2016-2017. Malaria journal, 2022, Mar-12, Volume: 21, Issue:1 Topics: Adolescent; Adult; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Chad; Child; Child, Preschool; Drug Resistance; Female; Humans; Male; Middle Aged; Plasmodium falciparum; Polymorphism, Genetic; Protozoan Proteins; Young Adult	2022
A single low dose of primaquine is safe and sufficient to reduce transmission of Plasmodium falciparum gametocytes regardless of cytochrome P450 2D6 enzyme activity in Bagamoyo district, Tanzania. Malaria journal, 2022, Mar-12, Volume: 21, Issue:1 Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Child; Child, Preschool; Cytochrome P-450 CYP2D6; Female; Humans; Infant; Plasmodium falciparum; Primaquine; Tanzania	2022
School-Based Malaria Screening and Treatment Reduces Plasmodium falciparum Infection and Anemia Prevalence in Two Transmission Settings in Malawi. The Journal of infectious diseases, 2022, 08-12, Volume: 226, Issue:1 Topics: Anemia; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Child; Humans; Malaria; Malaria, Falciparum; Malawi; Plasmodium falciparum; Prevalence; Prospective Studies; Schools	2022
Plasmodium malariae after successful treatment of P. falciparum malaria with artemether-lumefantrine. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2022, Volume: 119 Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Drug Combinations; Fluorenes; Humans; Malaria; Malaria, Falciparum; Plasmodium falciparum; Plasmodium malariae	2022
Health care provider practices in diagnosis and treatment of malaria in rural communities in Kisumu County, Kenya. Malaria journal, 2022, Apr-22, Volume: 21, Issue:1 Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Diagnostic Tests, Routine; Fever; Health Personnel; Humans; Kenya; Malaria; Malaria, Falciparum; Real-Time Polymerase Chain Reaction; Rural Population; Sensitivity and Specificity	2022
Artesunate-amodiaquine and artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in Liberia: in vivo efficacy and frequency of molecular markers. Malaria journal, 2022, Apr-27, Volume: 21, Issue:1 Topics: Amodiaquine; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artesunate; Child; Chloroquine; DNA Copy Number Variations; Female; Humans; Liberia; Malaria; Malaria, Falciparum; Membrane Transport Proteins; Plasmodium falciparum; Pregnancy	2022
Prevalence of malaria among febrile patients and assessment of efficacy of artemether-lumefantrine and artesunate-amodiaquine for uncomplicated malaria in Dolisie, Republic of the Congo. Malaria journal, 2022, May-02, Volume: 21, Issue:1 Topics: Amodiaquine; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artesunate; Child; Congo; Drug Combinations; Fever; Humans; Malaria; Parasitemia; Prevalence	2022
Prevalence of arps10, fd, pfmdr-2, pfcrt and pfkelch13 gene mutations in Plasmodium falciparum parasite population in Uganda. PloS one, 2022, Volume: 17, Issue:5 Topics: Animals; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Drug Resistance; Malaria; Malaria, Falciparum; Mutation; Parasites; Plasmodium falciparum; Prevalence; Protozoan Proteins; Uganda	2022
[Monitoring the Efficacy of Artemether-Lumefantrine in the Treatment of Uncomplicated Medecine tropicale et sante internationale, 2021, 03-31, Volume: 1, Issue:1 Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Central African Republic; Child; Cross-Sectional Studies; Drug Combinations; Ethanolamines; Fluorenes; Humans; Malaria; Malaria, Falciparum; Mutation; Treatment Outcome	2021
The effect of sickle cell genotype on the pharmacokinetic properties of artemether-lumefantrine in Tanzanian children. International journal for parasitology. Drugs and drug resistance, 2022, Volume: 19 Topics: Anemia, Sickle Cell; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Child; Ethanolamines; Fluorenes; Genotype; Humans; Lumefantrine; Malaria; Malaria, Falciparum; Tanzania	2022
Attitudes, practices, and determinants of community care-seeking behaviours for fever/malaria episodes in the context of the implementation of multiple first-line therapies for uncomplicated malaria in the health district of Kaya, Burkina Faso. Malaria journal, 2022, May-30, Volume: 21, Issue:1 Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Burkina Faso; Child; Cross-Sectional Studies; Female; Fever; Humans; Malaria; Patient Acceptance of Health Care; Pregnancy	2022
Cost-Utility Analysis of Community Case Management for Malaria Control in Burundi. International journal of health policy and management, 2022, 12-19, Volume: 11, Issue:12 Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Burundi; Case Management; Child; Child, Preschool; Cost-Benefit Analysis; Humans; Malaria	2022
Multiple Plasmodium falciparum drug resistance polymorphisms identified in a pregnant woman with severe malaria and a concomitant spontaneous abortion in Cross River, Nigeria, West Africa. Malaria journal, 2022, Jun-03, Volume: 21, Issue:1 Topics: Abortion, Spontaneous; Adult; Africa, Western; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Drug Resistance; Drug Resistance, Multiple; Female; Humans; Malaria; Malaria, Falciparum; Nigeria; Plasmodium falciparum; Pregnancy; Pregnant Women; Quinine	2022
Quinine plus clindamycin vs artemether-lumefantrine for treatment of uncomplicated falciparum malaria in western Kenya. Malaria journal, 2022, 06-21, Volume: 21, Issue:1 Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Clindamycin; Drug Combinations; Ethanolamines; Fluorenes; Humans; Kenya; Malaria, Falciparum; Quinine	2022
Transmission Blocking Activity of Low-dose Tafenoquine in Healthy Volunteers Experimentally Infected With Plasmodium falciparum. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2023, 02-08, Volume: 76, Issue:3 Topics: Adult; Animals; Anopheles; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Healthy Volunteers; Humans; Malaria; Malaria, Falciparum; Plasmodium falciparum; Sporozoites	2023
Stakeholder perceptions on the deployment of multiple first-line therapies for uncomplicated malaria: a qualitative study in the health district of Kaya, Burkina Faso. Malaria journal, 2022, Jun-27, Volume: 21, Issue:1 Topics: Amodiaquine; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Burkina Faso; Drug Combinations; Drug Therapy, Combination; Humans; Malaria; Malaria, Falciparum; Naphthyridines	2022
Malaria Transmission Dynamics in a High-Transmission Setting of Western Kenya and the Inadequate Treatment Response to Artemether-Lumefantrine in an Asymptomatic Population. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2023, 02-18, Volume: 76, Issue:4 Topics: Animals; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Humans; Kenya; Malaria; Malaria, Falciparum; Parasitemia; Plasmodium falciparum	2023
Plasmodium falciparum merozoite invasion ligands, linked antimalarial resistance loci and ex vivo responses to antimalarials in The Gambia. The Journal of antimicrobial chemotherapy, 2022, 10-28, Volume: 77, Issue:11 Topics: Animals; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Drug Resistance; Gambia; Ligands; Lumefantrine; Malaria; Malaria, Falciparum; Merozoites; Plasmodium falciparum; Protozoan Proteins	2022
Pre-existing partner-drug resistance to artemisinin combination therapies facilitates the emergence and spread of artemisinin resistance: a consensus modelling study. The Lancet. Microbe, 2022, Volume: 3, Issue:9 Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Consensus; Drug Resistance; Humans; Malaria, Falciparum; Plasmodium falciparum	2022
Persistence of Residual Submicroscopic P. falciparum Parasitemia following Treatment of Artemether-Lumefantrine in Ethio-Sudan Border, Western Ethiopia. Antimicrobial agents and chemotherapy, 2022, 09-20, Volume: 66, Issue:9 Topics: Adolescent; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Disease Progression; Ethanolamines; Ethiopia; Fluorenes; Humans; Malaria; Malaria, Falciparum; Parasitemia; Plasmodium falciparum; Sudan; Treatment Outcome	2022
Efficacy of Artemether-Lumefantrine and Dihydroartemisinin-Piperaquine for the Treatment of Uncomplicated Plasmodium falciparum Malaria among Children in Western Kenya, 2016 to 2017. Antimicrobial agents and chemotherapy, 2022, 09-20, Volume: 66, Issue:9 Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Drug Combinations; Ethanolamines; Fluorenes; Folic Acid Antagonists; Humans; Infant; Kenya; Malaria; Malaria, Falciparum; Piperazines; Plasmodium falciparum; Quinolines; Reinfection	2022
Preparation and application of a specific single-chain variable fragment against artemether. Journal of pharmaceutical and biomedical analysis, 2022, Oct-25, Volume: 220 Topics: Antibodies, Monoclonal; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; DNA, Recombinant; Enzyme-Linked Immunosorbent Assay; Single-Chain Antibodies	2022
Lumefantrine plasma concentrations in uncontrolled conditions among patients treated with artemether-lumefantrine for uncomplicated plasmodium falciparum malaria in Mwanza, Tanzania. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2022, Volume: 123 Topics: Adult; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Lumefantrine; Malaria; Malaria, Falciparum; Male; Plasmodium falciparum; Tanzania; Treatment Outcome	2022
High prevalence of Pfcrt 76T and Pfmdr1 N86 genotypes in malaria infected patients attending health facilities in East Shewa zone, Oromia Regional State, Ethiopia. Malaria journal, 2022, Oct-07, Volume: 21, Issue:1 Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Chloroquine; Drug Resistance; Ethiopia; Genotype; Health Facilities; Humans; Malaria; Malaria, Falciparum; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Prevalence; Protozoan Proteins	2022
Impact of Drug Exposure on Resistance Selection Following Artemether-Lumefantrine Treatment for Malaria in Children With and Without HIV in Uganda. Clinical pharmacology and therapeutics, 2023, Volume: 113, Issue:3 Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Drug Combinations; Fluorenes; HIV Infections; Humans; Lopinavir; Lumefantrine; Malaria; Malaria, Falciparum; Nevirapine; Ritonavir; Uganda	2023
Plasmodium falciparum community prevalence and health-seeking behaviours in rural Sussundenga District, Mozambique. Malaria journal, 2022, Oct-28, Volume: 21, Issue:1 Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Cross-Sectional Studies; Humans; Malaria; Malaria, Falciparum; Mozambique; Patient Acceptance of Health Care; Plasmodium falciparum; Prevalence	2022
Molecular surveillance for anti-malarial drug resistance and genetic diversity of Plasmodium falciparum after chloroquine and sulfadoxine-pyrimethamine withdrawal in Quibdo, Colombia, 2018. Malaria journal, 2022, Oct-28, Volume: 21, Issue:1 Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Chloroquine; Codon; Colombia; Drug Combinations; Drug Resistance; Humans; Malaria, Falciparum; Plasmodium falciparum; Polymorphism, Genetic; Pyrimethamine; Sulfadoxine	2022
Frontiers in cellular and infection microbiology, 2022, Volume: 12 Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Chloroquine; Ghana; Humans; Lumefantrine; Malaria, Falciparum; Plasmodium falciparum; Protozoan Proteins; Pyrimethamine	2022
High prevalence of persistent residual parasitemia on days 3 and 14 after artemether-lumefantrine or pyronaridine-artesunate treatment of uncomplicated Plasmodium falciparum malaria in Nigeria. Parasitology research, 2023, Volume: 122, Issue:2 Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Humans; Malaria, Falciparum; Merozoite Surface Protein 1; Nigeria; Parasitemia; Plasmodium falciparum; Prevalence	2023
Pattern and predictors of medication use among adults in southwestern Nigeria: A community-based cross-sectional study. Pharmacology research & perspectives, 2023, Volume: 11, Issue:1 Topics: Adult; Analgesics; Anti-Bacterial Agents; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Cross-Sectional Studies; Humans; Male; Middle Aged; Nigeria; Young Adult	2023
Safety and therapeutic efficacy of artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria at Shecha health centre, Arba Minch, Ethiopia. Malaria journal, 2023, Jan-07, Volume: 22, Issue:1 Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Drug Combinations; Ethanolamines; Ethiopia; Fever; Fluorenes; Humans; Infant; Malaria, Falciparum; Plasmodium falciparum; Treatment Outcome	2023
Return to Travel in the Coronavirus Disease 2019 Pandemic Recovery Period and Implications for Imported Malaria: Reinforcing Prevention, Early Diagnosis, and Appropriate Treatment of Malaria. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2023, 04-03, Volume: 76, Issue:7 Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artesunate; COVID-19; COVID-19 Testing; Early Diagnosis; Humans; Malaria; Malaria, Falciparum; Pandemics; Travel; United States	2023
Characterizing the Blood-Stage Antimalarial Activity of Tafenoquine in Healthy Volunteers Experimentally Infected With Plasmodium falciparum. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2023, 06-08, Volume: 76, Issue:11 Topics: Adult; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Australia; Healthy Volunteers; Humans; Malaria, Falciparum; Parasitemia; Plasmodium falciparum	2023
Assessment of artemisinin tolerance in Plasmodium falciparum clinical isolates in children with uncomplicated malaria in Ghana. Malaria journal, 2023, Feb-19, Volume: 22, Issue:1 Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Drug Combinations; Drug Tolerance; Ghana; Humans; Lumefantrine; Malaria; Malaria, Falciparum; Plasmodium falciparum	2023
Novel Plasmodium falciparum k13 gene polymorphisms from Kisii County, Kenya during an era of artemisinin-based combination therapy deployment. Malaria journal, 2023, Mar-09, Volume: 22, Issue:1 Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Drug Resistance; Humans; Kenya; Malaria, Falciparum; Plasmodium falciparum; Polymorphism, Single Nucleotide; Protozoan Proteins	2023
Effectiveness of community case management of malaria on severe malaria and inpatient malaria deaths in Zambia: a dose-response study using routine health information system data. Malaria journal, 2023, Mar-17, Volume: 22, Issue:1 Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Case Management; Child; Community Health Workers; Health Information Systems; Humans; Inpatients; Malaria; Retrospective Studies; Zambia	2023
Anti-malarial drug use, appropriateness and associated factors among children under-five with febrile illnesses presenting to a tertiary health facility: a cross sectional study. Malaria journal, 2023, Mar-21, Volume: 22, Issue:1 Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Cross-Sectional Studies; Fever; Humans; Malaria	2023
Weight-related malaria treatment failure with artemether-lumefantrine. Journal of travel medicine, 2023, 05-18, Volume: 30, Issue:3 Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Drug Combinations; Ethanolamines; Fluorenes; Humans; Malaria; Malaria, Falciparum; Treatment Failure	2023
Impact assessment of Intensified Malaria Control Project in transitioning a high malaria-endemic district to a low-endemic district: an epidemiological aspect. Pathogens and global health, 2023, Volume: 117, Issue:5 Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Humans; Malaria; Malaria, Falciparum; Malaria, Vivax; Plasmodium falciparum; Plasmodium vivax	2023
[Domestic Malaria Cases in Kayseri Province]. Mikrobiyoloji bulteni, 2023, Volume: 57, Issue:2 Topics: Adolescent; Animals; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Humans; Malaria; Malaria, Falciparum; Malaria, Vivax; Male; Parasitemia; Travel	2023
Prevalence, trends and associated factors of malaria in the Shai-Osudoku District Hospital, Ghana. Malaria journal, 2023, Apr-22, Volume: 22, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Child; Child, Preschool; Cross-Sectional Studies; Ghana; Hospitals, District; Humans; Infant; Malaria; Malaria, Falciparum; Middle Aged; Prevalence; Young Adult	2023
Design, Implementation, and Coordination of Malaria Therapeutic Efficacy Studies in Nigeria in 2018. The American journal of tropical medicine and hygiene, 2023, 06-07, Volume: 108, Issue:6 Topics: Amodiaquine; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Child; Drug Combinations; Ethanolamines; Fluorenes; Humans; Malaria; Malaria, Falciparum; Nigeria	2023
Plasmodium falciparum kelch13 polymorphisms identified after treatment failure with artemisinin-based combination therapy in Niger. Malaria journal, 2023, May-01, Volume: 22, Issue:1 Topics: Amodiaquine; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Drug Combinations; Humans; Malaria, Falciparum; Niger; Plasmodium falciparum; Polymorphism, Single Nucleotide; Treatment Failure	2023
Prevalence of mutations in the cysteine desulfurase IscS (Pfnfs1) gene in recurrent Plasmodium falciparum infections following artemether-lumefantrine (AL) and dihydroartemisinin-piperaquine (DP) treatment in Matayos, Western Kenya. Malaria journal, 2023, May-19, Volume: 22, Issue:1 Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Drug Combinations; Humans; Kenya; Lumefantrine; Malaria; Malaria, Falciparum; Mutation; Plasmodium falciparum; Prevalence; Quinolines; Reinfection	2023
Cost of inappropriate prescriptions for uncomplicated malaria in Ghana. Malaria journal, 2023, May-18, Volume: 22, Issue:1 Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Ghana; Humans; Inappropriate Prescribing; Malaria; Retrospective Studies	2023
Pharmacopeial quality of artemether-lumefantrine anti-malarial agents in Uganda. Malaria journal, 2023, May-26, Volume: 22, Issue:1 Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Cross-Sectional Studies; Humans; Lumefantrine; Malaria; Malaria, Falciparum; Uganda	2023
Vitamin C-rich juice co-administration with artemether-lumefantrine ameliorates oxido-inflammatory responses in Plasmodium berghei-infected mice. Parasitology research, 2023, Volume: 122, Issue:8 Topics: Animals; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Ascorbic Acid; Interleukin-6; Malaria; Malondialdehyde; Mice; Parasitemia; Plasmodium berghei; Superoxide Dismutase; Tumor Necrosis Factor-alpha	2023
Clinical isolates of uncomplicated falciparum malaria from high and low malaria transmission areas show distinct pfcrt and pfmdr1 polymorphisms in western Ethiopia. Malaria journal, 2023, Jun-03, Volume: 22, Issue:1 Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Chloroquine; Drug Resistance; Ethiopia; Humans; Lumefantrine; Malaria; Malaria, Falciparum; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Polymorphism, Single Nucleotide; Protozoan Proteins	2023
Polymorphism analysis of drug resistance markers in Plasmodium falciparum isolates from Benin. Acta tropica, 2023, Volume: 245 Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Benin; Drug Combinations; Drug Resistance; Humans; Malaria; Malaria, Falciparum; Plasmodium falciparum; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase	2023
[A Marginal Case of Malaria: An Interesting Malaria Story of Cameroon Origin]. Mikrobiyoloji bulteni, 2023, Volume: 57, Issue:3 Topics: Animals; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Cameroon; Coinfection; Humans; Malaria; Malaria, Vivax; Male; Middle Aged; Plasmodium; Plasmodium falciparum; Plasmodium vivax; Real-Time Polymerase Chain Reaction	2023
Prescription patterns and compliance with World Health Organization recommendations for the management of uncomplicated and severe malaria: A prospective, real-world study in sub-Saharan Africa. Malaria journal, 2023, Jul-25, Volume: 22, Issue:1 Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Drug Combinations; Humans; Infant, Newborn; Malaria; Malaria, Falciparum; Prescriptions; Prospective Studies; Tanzania; World Health Organization	2023
Preventing antimalarial drug resistance with triple artemisinin-based combination therapies. Nature communications, 2023, 07-29, Volume: 14, Issue:1 Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Folic Acid Antagonists	2023
Therapeutic efficacy of artesunate-amodiaquine and artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in Chad: clinical and genetic surveillance. Malaria journal, 2023, Aug-23, Volume: 22, Issue:1 Topics: Adult; Amodiaquine; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Chad; Female; Humans; Malaria, Falciparum; Pregnancy; Prospective Studies	2023
Malaria in Pregnancy: Key Points for the Neonatologist. NeoReviews, 2023, 09-01, Volume: 24, Issue:9 Topics: Adult; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Child; Female; Humans; Infant; Infant, Newborn; Malaria; Neonatologists; Pregnancy; Premature Birth	2023
Healthcare provider and drug dispenser knowledge and adherence to guidelines for the case management of malaria in pregnancy in the context of multiple first-line artemisinin-based combination therapy in western Kenya. Malaria journal, 2023, Sep-08, Volume: 22, Issue:1 Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Case Management; Cross-Sectional Studies; Female; Humans; Kenya; Malaria; Pregnancy; Quinine	2023
Perceptions and drivers of healthcare provider and drug dispenser practices for the treatment of malaria in pregnancy in the context of multiple first-line therapies in western Kenya: a qualitative study. Malaria journal, 2023, Sep-14, Volume: 22, Issue:1 Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Female; Health Personnel; Humans; Kenya; Malaria; Pharmaceutical Preparations; Pregnancy; Quinine	2023
Modeling policy interventions for slowing the spread of artemisinin-resistant pfkelch R561H mutations in Rwanda. Nature medicine, 2023, Volume: 29, Issue:11 Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Drug Resistance; Humans; Malaria, Falciparum; Mutation; Plasmodium falciparum; Rwanda	2023
Determine the enzymatic kinetic characteristics of CYP3A4 variants utilizing artemether-lumefantrine. Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 2023, Volume: 181 Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Cytochrome P-450 CYP3A; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Molecular Docking Simulation	2023
The public health response to a Plasmodium malariae outbreak in Penampang district, Sabah during a COVID-19 movement control order. Malaria journal, 2023, Oct-03, Volume: 22, Issue:1 Topics: Animals; Anopheles; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; COVID-19; Disease Outbreaks; Female; Humans; Malaria; Malaysia; Male; Mosquito Vectors; Pandemics; Plasmodium knowlesi; Plasmodium malariae; Public Health	2023
Adherence to national malaria treatment guidelines in private drug outlets: a cross-sectional survey in the malaria-endemic Kisumu County, Kenya. Malaria journal, 2023, Oct-11, Volume: 22, Issue:1 Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Cross-Sectional Studies; Fever; Humans; Kenya; Malaria; Surveys and Questionnaires	2023
Attractive targeted sugar bait: the pyrrole insecticide chlorfenapyr and the anti-malarial pharmaceutical artemether-lumefantrine arrest Plasmodium falciparum development inside wild pyrethroid-resistant Anopheles gambiae s.s. mosquitoes. Malaria journal, 2023, Nov-09, Volume: 22, Issue:1 Topics: Animals; Anopheles; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Carbohydrates; Female; Humans; Insecticide Resistance; Insecticides; Malaria; Malaria, Falciparum; Male; Mosquito Control; Mosquito Vectors; Plasmodium falciparum; Pyrethrins; Sugars	2023